Cargando…
P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428997/ http://dx.doi.org/10.1097/01.HS9.0000846336.64675.44 |
_version_ | 1784779294515396608 |
---|---|
author | Pfeiffer, C. Beer, P. Asnagli, H. Bolomsky, A. Grandits, A. Schneller, A. Huber, J. Zojer, N. Schreder, M. Parker, A. Ludwig, H. |
author_facet | Pfeiffer, C. Beer, P. Asnagli, H. Bolomsky, A. Grandits, A. Schneller, A. Huber, J. Zojer, N. Schreder, M. Parker, A. Ludwig, H. |
author_sort | Pfeiffer, C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9428997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94289972022-08-31 P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION Pfeiffer, C. Beer, P. Asnagli, H. Bolomsky, A. Grandits, A. Schneller, A. Huber, J. Zojer, N. Schreder, M. Parker, A. Ludwig, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428997/ http://dx.doi.org/10.1097/01.HS9.0000846336.64675.44 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Pfeiffer, C. Beer, P. Asnagli, H. Bolomsky, A. Grandits, A. Schneller, A. Huber, J. Zojer, N. Schreder, M. Parker, A. Ludwig, H. P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION |
title | P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION |
title_full | P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION |
title_fullStr | P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION |
title_full_unstemmed | P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION |
title_short | P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION |
title_sort | p864: ctps1 is a novel therapeutic target in myeloma - selective small molecule inhibition delivers single agent activity and synergises with atr inhibition |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428997/ http://dx.doi.org/10.1097/01.HS9.0000846336.64675.44 |
work_keys_str_mv | AT pfeifferc p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT beerp p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT asnaglih p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT bolomskya p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT granditsa p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT schnellera p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT huberj p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT zojern p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT schrederm p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT parkera p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition AT ludwigh p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition |